Table 2: The results of phospho-IκBα-relative expression, 8-OHdG-immunoreactive cells (%), and cyclin D1-immunoreactive cells (%).

Parameters/Group CO ( 𝑁 = 6 ) CC ( 𝑁 = 6 )MNU + s-NaCl ( 𝑁 = 6 )MNU + s-NaCl + C3W ( 𝑁 = 5 )MNU + s-NaCl + C20W ( 𝑁 = 6 )
C3W benign ( 𝑁 = 2 )C3W cancer ( 𝑁 = 3 )C20W benign ( 𝑁 = 3 )C20W cancer ( 𝑁 = 3 )

Phospho-IκBα 0 . 5 1 ± 0 . 1 1 0 . 5 4 ± 0 . 1 8 0 . 8 2 ± 0 . 1 8 * 0 . 4 6 ± 0 . 0 4 0 . 6 0 ± 0 . 2 9 0 . 5 1 ± 0 . 0 8 1 . 1 6 ± 0 . 3 4 **,†
8-OHdG 4 4 . 4 2 ± 3 . 4 1 †† 4 0 . 3 9 ± 3 . 5 3 †† 5 3 . 0 6 ± 5 . 9 6 ** 4 9 . 2 8 ± 7 . 4 3 4 8 . 0 6 ± 3 . 4 7 4 4 . 9 9 ± 3 . 5 1 4 7 . 7 7 ± 2 . 5 5
Cyclin D1 3 8 . 5 8 ± 5 . 3 7 †† 4 2 . 5 3 ± 6 . 9 0 †† 5 4 . 9 1 ± 7 . 9 3 ** 4 . 3 3 ± 1 . 2 7 * 5 4 . 9 2 ± 3 . 8 7 ** 4 5 . 3 1 ± 6 . 2 9 5 3 . 8 2 ± 1 1 . 0 1 **

These data were presented as the mean ± SD. *Represented significant difference compared with CO group ( 𝑃 < 0 . 0 5 ). **Represented significant difference compared with CO group ( 𝑃 < 0 . 0 1 ). Represented significant difference compared with MNU + s-NaCl group ( 𝑃 < 0 . 0 5 ). ††Represented significant difference compared with MNU + s-NaCl group ( 𝑃 < 0 . 0 1 ).